<?xml version="1.0" encoding="UTF-8"?>
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="JATS-archive-oasis-article1-4.xsd" article-type="research-article" dtd-version="1.4" xml:lang="ru">
  <front>
    <journal-meta>
      <journal-title-group>
        <journal-title>Журнал Современные проблемы науки и образования</journal-title>
      </journal-title-group>
      <issn>2070-7428</issn>
      <publisher>
        <publisher-name>Общество с ограниченной ответственностью &amp;quot;Издательский Дом &amp;quot;Академия Естествознания&amp;quot;</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.17513/spno.34689</article-id>
      <article-id pub-id-type="publisher-id">ART-34689</article-id>
      <title-group>
        <article-title>МАТЕМАТИЧЕСКОЕ МОДЕЛИРОВАНИЕ В ЭПИДЕМИОЛОГИИ ЛЕПРЫ: МЕТОДОЛОГИЧЕСКИЕ ПОДХОДЫ И ОБОСНОВАНИЕ ВЫБОРА МОДЕЛИ</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name-alternatives>
            <name xml:lang="ru">
              <surname>Янчевская</surname>
              <given-names>Е.Ю.</given-names>
            </name>
          </name-alternatives>
          <name-alternatives>
            <name xml:lang="en">
              <surname>Yanchevskaya</surname>
              <given-names>E.Y.</given-names>
            </name>
          </name-alternatives>
          <email>apteca-111a@mail.ru</email>
          <xref ref-type="aff" rid="aff01e401e0"/>
        </contrib>
        <contrib contrib-type="author">
          <name-alternatives>
            <name xml:lang="ru">
              <surname>Сердюков</surname>
              <given-names>А.Г.</given-names>
            </name>
          </name-alternatives>
          <name-alternatives>
            <name xml:lang="en">
              <surname>Serdyukov</surname>
              <given-names>A.G.</given-names>
            </name>
          </name-alternatives>
          <email>agma@astranet.ru</email>
          <xref ref-type="aff" rid="aff01e401e0"/>
        </contrib>
        <contrib contrib-type="author">
          <name-alternatives>
            <name xml:lang="ru">
              <surname>Воронина</surname>
              <given-names>Л.П.</given-names>
            </name>
          </name-alternatives>
          <name-alternatives>
            <name xml:lang="en">
              <surname>Voronina</surname>
              <given-names>L.P.</given-names>
            </name>
          </name-alternatives>
          <email>voroninaluda74@mail.ru</email>
          <xref ref-type="aff" rid="aff01e401e0"/>
        </contrib>
      </contrib-group>
      <aff id="aff01e401e0">
        <institution xml:lang="ru">Федеральное государственное бюджетное образовательное учреждение высшего образования «Астраханский государственный медицинский университет» Министерства здравоохранения Российской Федерации</institution>
        <institution xml:lang="en">Astrakhan State Medical University</institution>
      </aff>
      <pub-date date-type="pub" iso-8601-date="2026-07-10">
        <day>10</day>
        <month>07</month>
        <year>2026</year>
      </pub-date>
      <issue>7</issue>
      <fpage>15</fpage>
      <lpage>15</lpage>
      <permissions>
        <license xlink:href="https://creativecommons.org/licenses/by/4.0/">
          <license-p>This is an open-access article distributed under the terms of the CC BY 4.0 license.</license-p>
        </license>
      </permissions>
      <self-uri content-type="url" hreflang="ru">https://science-education.ru/ru/article/view?id=34689</self-uri>
      <abstract xml:lang="ru" lang-variant="original" lang-source="author">
        <p>надёжного инструментария для прогнозирования и оценки вмешательств. Цель - систематически проанализировать методологические подходы к математическому моделированию в эпидемиологии лепры и обосновать алгоритм выбора оптимальной модели в зависимости от исследовательского вопроса и доступных данных. Проведён анализ литературы в базах данных PubMed/MEDLINE, Scopus и Web of Science за 1970–2024 гг.; в список литературы включено 32 источника. В мировой практике применяются три класса моделей: детерминированные компартментные (SIR, SEIR, SIMLEP, SIMCOLEP), стохастические индивидуально ориентированные и модели временны́х рядов (ARIMA/SARIMA). Компартментные и стохастические модели наиболее целесообразны для оценки R₀ и долгосрочного сценарного анализа; SARIMA показала применимость в отдельных исследованиях краткосрочного прогнозирования по данным надзора. Выявлены ключевые методологические проблемы: занижение регистрации случаев, параметрическая неопределённость, роль зоонозного резервуара и пространственная гетерогенность заболеваемости. Обоснованы минимальные структурные требования к адекватной модели лепры и предложен пятишаговый алгоритм выбора типа модели. Выбор модели должен определяться исследовательским вопросом, горизонтом прогноза и качеством данных; стандартизация подходов к отчётности о моделях является необходимым условием для трансляции результатов в политику здравоохранения.</p>
      </abstract>
      <abstract xml:lang="en" lang-variant="translation" lang-source="translator">
        <p>Leprosy (Hansen's disease) remains a significant public health problem: approximately 200,000 new cases are registered worldwide annually, and the WHO elimination goals for 2030 require reliable tools for forecasting and intervention assessment. Aim - to systematically analyze methodological approaches to mathematical modeling in leprosy epidemiology and justify a decision-making algorithm for optimal model selection depending on the research question and available data. A literature search was conducted in PubMed/MEDLINE, Scopus, and Web of Science databases for the period 1970–2024; 32 sources were included in the reference list. Three classes of models are used in global practice: deterministic compartmental models (SIR, SEIR, SIMLEP, SIMCOLEP), stochastic individual-based simulations, and time series models (ARIMA/SARIMA). Compartmental and stochastic models are most appropriate for estimating R₀ and long-term scenario analysis; SARIMA has demonstrated applicability in selected short-term forecasting studies based on surveillance data. Key methodological challenges were identified: underreporting of cases, parametric uncertainty, the role of the zoonotic reservoir, and spatial heterogeneity of incidence. Minimum structural requirements for an adequate leprosy model are substantiated, and a five-step model selection algorithm is proposed. Model choice should be determined by the research question, forecast horizon, and data quality; standardization of modeling and reporting approaches is a necessary condition for translating results into public health policy.</p>
      </abstract>
      <kwd-group xml:lang="ru">
        <kwd>лепра</kwd>
        <kwd>болезнь хансена</kwd>
        <kwd>математическое моделирование</kwd>
        <kwd>компартментные модели</kwd>
        <kwd>arima</kwd>
        <kwd>sarima</kwd>
        <kwd>анализ временны́х рядов</kwd>
        <kwd>базовое репродуктивное число</kwd>
        <kwd>эпидемиологический надзор</kwd>
        <kwd>элиминация</kwd>
      </kwd-group>
      <kwd-group xml:lang="en">
        <kwd>leprosy</kwd>
        <kwd>hansen's disease</kwd>
        <kwd>mathematical modeling</kwd>
        <kwd>compartmental models</kwd>
        <kwd>arima</kwd>
        <kwd>sarima</kwd>
        <kwd>time series analysis</kwd>
        <kwd>basic reproduction number</kwd>
        <kwd>epidemiological surveillance</kwd>
        <kwd>elimination</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <back>
    <ref-list>
      <ref>
        <note>
          <p>1.	World Health Organization. Global leprosy (Hansen disease) update, 2023: elimination of leprosy disease is possible – time to act! Wkly Epidemiol Rec. 2024;99(37):501–521. URL: https://iris.who.int/handle/10665/378893.</p>
        </note>
      </ref>
      <ref>
        <note>
          <p>2.	World Health Organization. Ending the neglect to attain the Sustainable Development Goals: a road map for neglected tropical diseases 2021–2030. Geneva: WHO; 2021. URL: https://www.who.int/publications/i/item/9789240010352.</p>
        </note>
      </ref>
      <ref>
        <note>
          <p>3.	World Health Organization. Global leprosy (Hansen disease) update, 2022: new paradigm – control to elimination. Wkly Epidemiol Rec. 2023;98(37):409–430. URL: https://www.who.int/publications/i/item/who-wer9837-409-430.</p>
        </note>
      </ref>
      <ref>
        <note>
          <p>4.	Avanzi C, Singh P, Truman RW, Suffys PN. Molecular epidemiology of leprosy: An update. Infect Genet Evol. 2020;86:104581. DOI: 10.1016/j.meegid.2020.104581. PMID: 33022427.URL: https://pubmed.ncbi.nlm.nih.gov/33022427.</p>
        </note>
      </ref>
      <ref>
        <note>
          <p>5.	Pierneef L, van Hooij A, Taal A, et al. Detection of anti-M. leprae antibodies in children in leprosy-endemic areas: a systematic review. PLoS Negl Trop Dis. 2021;15(8):e0009667. DOI: 10.1371/journal.pntd.0009667. PMID: 34449763. URL: https://pubmed.ncbi.nlm.nih.gov/34449763.</p>
        </note>
      </ref>
      <ref>
        <note>
          <p>6.	Blok DJ, de Vlas SJ, Fischer EAJ, Richardus JH. Mathematical modelling of leprosy and its control. Adv Parasitol. 2015;87:33–51. DOI: 10.1016/bs.apar.2014.12.002. PMID: 25765193. URL: https://pubmed.ncbi.nlm.nih.gov/25765193.</p>
        </note>
      </ref>
      <ref>
        <note>
          <p>7.	Lechat MF, Misson JY, Vellut CM, Misson CB, Bouckaert A. An epidemetric model of leprosy. Bull World Health Organ. 1974;51(4):361–373. PMID: 4549490. PMC: PMC2366301. URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC2366301.</p>
        </note>
      </ref>
      <ref>
        <note>
          <p>8.	Meima A, Gupte MD, van Oortmarssen GJ, Habbema JDF. SIMLEP: a simulation model for leprosy transmission and control. Int J Lepr Other Mycobact Dis. 1999;67(3):215–236. PMID: 10575401. URL: https://pubmed.ncbi.nlm.nih.gov/10575401.</p>
        </note>
      </ref>
      <ref>
        <note>
          <p>9.	Meima A, Smith WC, van Oortmarssen GJ, Richardus JH, Habbema JDF. The future incidence of leprosy: a scenario analysis. Bull World Health Organ. 2004;82(5):373–380. PMID: 15298228. URL: https://pubmed.ncbi.nlm.nih.gov/15298228.</p>
        </note>
      </ref>
      <ref>
        <note>
          <p>10.	Fischer EAJ, de Vlas SJ, Meima A, Habbema JDF, Richardus JH. Different mechanisms for heterogeneity in leprosy susceptibility can explain disease clustering within households. PLoS ONE. 2010;5(11):e14061. DOI: 10.1371/journal.pone.0014061. PMID: 21124916. PMC: PMC2988824. URL: https://pubmed.ncbi.nlm.nih.gov/21124916.</p>
        </note>
      </ref>
      <ref>
        <note>
          <p>11.	Blok DJ., Steinmann P, Tiwari A, Barth-Jaeggi T, Arif MA, Banstola NL, et al. The long-term impact of the Leprosy Post-Exposure Prophylaxis (LPEP) program on leprosy incidence: A modelling study. PLoS Negl Trop Dis. 2021;15(3):e0009279. DOI: 10.1371/journal.pntd.0009279. URL: https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0009279.</p>
        </note>
      </ref>
      <ref>
        <note>
          <p>12.	Smith RL. Proposing a compartmental model for leprosy and parameterizing using regional incidence in Brazil. PLoS Negl Trop Dis. 2016;10(8):e0004925. DOI: 10.1371/journal.pntd.0004925. PMID: 27532862. PMC: PMC4993072. URL: https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0004925.</p>
        </note>
      </ref>
      <ref>
        <note>
          <p>13.	Medley GF, Blok DJ, Crump RE, Hollingsworth TD, Galvani AP, Ndeffo-Mbah M.L, Porco T.C, Richardus JH. Policy lessons from quantitative modeling of leprosy. Clin Infect Dis. 2018;66(Suppl 4):S281–S285. DOI: 10.1093/cid/ciy005. PMID: 29860289. URL: https://pubmed.ncbi.nlm.nih.gov/29860289.</p>
        </note>
      </ref>
      <ref>
        <note>
          <p>14.	Lechat MF. The torments and blessings of the leprosy epidemiometric model. Lepr Rev. 1981;52(Suppl 1):187–196. DOI: 10.5935/0305-7518.19810069. PMID: 7339395. URL: https://pubmed.ncbi.nlm.nih.gov/7339395.</p>
        </note>
      </ref>
      <ref>
        <note>
          <p>15.	Meima A, Irgens LM, van Oortmarssen GJ, Richardus JH, Habbema JDF. Disappearance of leprosy from Norway: an exploration of critical factors using an epidemiological modelling approach. Int J Epidemiol. 2002;31(5):991–1000. DOI: 10.1093/ije/31.5.991. PMID: 12435774. URL: https://pubmed.ncbi.nlm.nih.gov/12435774.</p>
        </note>
      </ref>
      <ref>
        <note>
          <p>16.	de Matos HJ, Blok DJ, de Vlas SJ, Richardus JH. Leprosy new case detection trends and the future effect of preventive interventions in Pará State, Brazil: a modelling study. PLoS Negl Trop Dis. 2016;10(3):e0004507. DOI: 10.1371/journal.pntd.0004507. PMID: 26938738. URL: https://pubmed.ncbi.nlm.nih.gov/26938738.</p>
        </note>
      </ref>
      <ref>
        <note>
          <p>17.	Hambridge T, Nanjan Chandran SL, Geluk A, Saunderson P, Richardus JH. Mycobacterium leprae transmission characteristics during the declining stages of leprosy incidence: a systematic review. PLoS Negl Trop Dis. 2021;15(5):e0009436. DOI: 10.1371/journal.pntd.0009436 URL: https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0009436.</p>
        </note>
      </ref>
      <ref>
        <note>
          <p>18.	Lietman T, Porco T, Blower S. Leprosy and tuberculosis: the epidemiological consequences of cross-immunity. Am J Public Health. 1997;87(12):1923–1927. DOI: 10.2105/ajph.87.12.1923. PMID: 9431277. URL: https://pubmed.ncbi.nlm.nih.gov/9431277.</p>
        </note>
      </ref>
      <ref>
        <note>
          <p>19.	Blok DJ, Crump RE, Sundaresh R, Ndeffo-Mbah M, Galvani AP, Porco TC, et al. Forecasting the new case detection rate of leprosy in four states of Brazil: a comparison of modelling approaches. Epidemics. 2017;18:92–100. DOI: 10.1016/j.epidem.2017.01.005. PMID: 28279460. URL: https://pubmed.ncbi.nlm.nih.gov/28279460.</p>
        </note>
      </ref>
      <ref>
        <note>
          <p>20.	Gregório V, Pedroza D, Barbosa C, Bezerra G, Montarroyos U, Bonfim C, Medeiros Z. Predicting the detection of leprosy in a hyperendemic area of Brazil: using time series analysis. Indian J Dermatol Venereol Leprol. 2021;87(5):651–659. DOI: 10.25259/IJDVL_1082_19. PMID: 33666042. URL: https://pubmed.ncbi.nlm.nih.gov/33666042.</p>
        </note>
      </ref>
      <ref>
        <note>
          <p>21.	Bailey TC, Carvalho MS, Lapa TM, Souza WV, Brewer MJ. Modeling of under-detection of cases in disease surveillance. Ann Epidemiol. 2005;15(5):335–343. DOI: 10.1016/j.annepidem.2004.09.013. PMID: 15840546. URL: https://pubmed.ncbi.nlm.nih.gov/15840546.</p>
        </note>
      </ref>
      <ref>
        <note>
          <p>22.	de Oliveira GL, Oliveira JF, Pescarini JM, Andrade RFS, Nery JS, Ichihara MY, et al. Estimating underreporting of leprosy in Brazil using a Bayesian approach. PLoS Negl Trop Dis. 2021;15(8):e0009700. DOI: 10.1371/journal.pntd.0009700. PMID: 34432805. URL: https://pubmed.ncbi.nlm.nih.gov/34432805.</p>
        </note>
      </ref>
      <ref>
        <note>
          <p>23.	Crump RE, Medley GF. Back-calculating the incidence of infection of leprosy in a Bayesian framework. Parasit Vectors. 2015;8:534. DOI: 10.1186/s13071-015-1142-5. PMID: 26490744. URL: https://pubmed.ncbi.nlm.nih.gov/26490744.</p>
        </note>
      </ref>
      <ref>
        <note>
          <p>24.	Truman RW, Singh P, Sharma R, Busso P, Rougemont J, Paniz-Mondolfi A, et al. Probable zoonotic leprosy in the southern United States. N Engl J Med. 2011;364(17):1626–1633. DOI: 10.1056/NEJMoa1010536. PMID: 21524213. URL: https://pubmed.ncbi.nlm.nih.gov/21524213.</p>
        </note>
      </ref>
      <ref>
        <note>
          <p>25.	Romero-Alvarez D, Calvopiña M, Cisneros-Vásquez E, Garzon-Chavez D, Warren AK, Bennett LS, et al. Mycobacterium leprae in nine-banded armadillos (Dasypus novemcinctus), Ecuador. Emerg Infect Dis. 2024;30(12):2629–2632. DOI: 10.3201/eid3012.231143. PMID: 39592404. URL: https://pubmed.ncbi.nlm.nih.gov/39592404.</p>
        </note>
      </ref>
      <ref>
        <note>
          <p>26.	Gilchrist JJ, Auckland K, Parks T, Mentzer AJ, Goldblatt L, Naranbhai V, et al. Genome-wide association study of leprosy in Malawi and Mali. PLoS Pathog. 2022;18(9):e1010312. DOI: 10.1371/journal.ppat.1010312. PMID: 36121873. URL: https://pubmed.ncbi.nlm.nih.gov/36121873.</p>
        </note>
      </ref>
      <ref>
        <note>
          <p>27.	Grantz KH, Chabaari W, Samuel RK, Gershom B, Blum L, Worden L, et al. Spatial distribution of leprosy in India: an ecological study. Infect Dis Poverty. 2018;7(1):20. DOI: 10.1186/s40249-018-0402-y. PMID: 29580296. URL: https://pubmed.ncbi.nlm.nih.gov/29580296/</p>
        </note>
      </ref>
      <ref>
        <note>
          <p>28.	Bulstra CA, Blok DJ, Alam K, Butlin CR, Roy JC, Bowers B, et al. Geospatial epidemiology of leprosy in northwest Bangladesh: a 20-year retrospective observational study. Infect Dis Poverty. 2021;10(1):36. DOI: 10.1186/s40249-021-00817-4. PMID: 33752751. URL: https://pubmed.ncbi.nlm.nih.gov/33752751/.</p>
        </note>
      </ref>
      <ref>
        <note>
          <p>29.	Schreuder PAM, Noto S, Richardus JH. Epidemiologic trends of leprosy for the 21st century. Clin Dermatol. 2016;34(1):24–31. DOI: 10.1016/j.clindermatol.2015.11.001. PMID: 26773620. URL: https://pubmed.ncbi.nlm.nih.gov/26773620/.</p>
        </note>
      </ref>
      <ref>
        <note>
          <p>30.	Dankwa EA, Brouwer AF, Donnelly CA. Structural identifiability of compartmental models for infectious disease transmission is influenced by data type. Epidemics. 2022;41:100643. DOI: 10.1016/j.epidem.2022.100643. PMID: 36308994. URL: https://pubmed.ncbi.nlm.nih.gov/36308994/.</p>
        </note>
      </ref>
      <ref>
        <note>
          <p>31.	Silal SP, Little F, Barnes KI, White LJ. Sensitivity to model structure: a comparison of compartmental models in epidemiology. Health Syst (Basingstoke). 2016;5(3):178–191. DOI: 10.1057/hs.2015.2. PMC: PMC7613485. URL: https://www.tandfonline.com/doi/full/10.1057/hs.2015.2.</p>
        </note>
      </ref>
      <ref>
        <note>
          <p>32.	Minter A, Retkute R. Approximate Bayesian Computation for infectious disease modelling. Epidemics. 2019;29:100368. DOI: 10.1016/j.epidem.2019.100368. PMID: 31563466. URL: https://pubmed.ncbi.nlm.nih.gov/31563466.</p>
        </note>
      </ref>
    </ref-list>
  </back>
</article>
